GlassScriptPhysician profile
Suzanne Adkins
NPI 1609122837
$4,947.63
in general payments reported to CMS, 2019-2025
22 companies · $290 in 2025
The $290 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $307 · 2020: $264 · 2021: $1,170 · 2022: $2,008 · 2023: $436 · 2024: $472 · 2025: $290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,161 · Entertainment: $36.77.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,160.88 |
| Entertainment | $36.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $906.73 | 2021-2025 | |
| Kala Pharmaceuticals, INC. | $713.08 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $711.03 | 2022-2025 | Cequa |
| Sight Sciences, INC. | $567.61 | 2020-2025 | Tearcare System |
| Allergan, INC. | $417.87 | 2019-2022 | |
| Dompe US, INC. | $278.73 | 2024-2025 | Oxervate |
| Bausch & Lomb Americas INC. | $248.44 | 2022-2023 | Infuse, Vyzulta, Prolensa |
| Alcon Vision LLC | $185.25 | 2020-2025 | Centurion, Precision 1 |
| Horizon Therapeutics Plc | $164.25 | 2021-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $129.85 | 2019-2020 | |
| Abbvie INC. | $116.72 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $113.92 | 2019-2021 | |
| Carl Zeiss Meditec USA, INC. | $87.50 | 2023 | Visumax |
| Harrow Eye, LLC | $56.53 | 2024 | |
| Glaukos Corporation | $53.19 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $41.18 | 2024 | Vabysmo |
| Oyster Point Pharma, INC. | $39.98 | 2022-2023 | Tyrvaya |
| Optos, INC. | $36.77 | 2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Quidel Corporation | $29.54 | 2022 | |
| Coopervision INC. | $17.64 | 2025 | Clariti Contact Lens |
| Aerie Pharmaceuticals, INC. | $16.09 | 2021 | |
| Carl Zeiss Meditec, INC. | $15.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suzanne Adkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.